ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Genome Assembly and Annotation Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-34V16649
Home | Market Reports | Science| Biological Sciences
Global Genome Assembly and Annotation Service Market Research Report 2024
BUY CHAPTERS

Global Genome Assembly and Annotation Service Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-34V16649
Report
November 2025
Pages:132
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Charles River
Lexogen GmbH
Natera
BGI
Illumina Inc
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link

Genome Assembly and Annotation Service Market

The global Genome Assembly and Annotation Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Hospitals and Clinics accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Genome Assembly and Annotation Service leading manufacturers including Charles River, Lexogen, Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences, etc., dominate supply; the top five capture approximately % of global revenue, with Charles River leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Genome Assembly and Annotation Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Genome Assembly and Annotation Service Market Report

Report Metric Details
Report Name Genome Assembly and Annotation Service Market
Segment by Type
  • Targeted Sequencing
  • Whole Exome Sequencing
  • Whole Genome Sequencing
Segment by Application
  • Hospitals and Clinics
  • Biopharma Companies
  • Academic & Research Organizations
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Charles River, Lexogen, Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences, Macrogen, Personalis, Novogene, Genotypic Technology, Dna Link
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Genome Assembly and Annotation Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Genome Assembly and Annotation Service Market report?

Ans: The main players in the Genome Assembly and Annotation Service Market are Charles River, Lexogen, Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences, Macrogen, Personalis, Novogene, Genotypic Technology, Dna Link

What are the Application segmentation covered in the Genome Assembly and Annotation Service Market report?

Ans: The Applications covered in the Genome Assembly and Annotation Service Market report are Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations, Others

What are the Type segmentation covered in the Genome Assembly and Annotation Service Market report?

Ans: The Types covered in the Genome Assembly and Annotation Service Market report are Targeted Sequencing, Whole Exome Sequencing, Whole Genome Sequencing

1 Study Coverage
1.1 Introduction to Genome Assembly and Annotation Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Genome Assembly and Annotation Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Targeted Sequencing
1.2.3 Whole Exome Sequencing
1.2.4 Whole Genome Sequencing
1.3 Market Segmentation by Application
1.3.1 Global Genome Assembly and Annotation Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Biopharma Companies
1.3.4 Academic & Research Organizations
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Genome Assembly and Annotation Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Genome Assembly and Annotation Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Genome Assembly and Annotation Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Genome Assembly and Annotation Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Targeted Sequencing Market Size by Players
3.3.2 Whole Exome Sequencing Market Size by Players
3.3.3 Whole Genome Sequencing Market Size by Players
3.4 Global Genome Assembly and Annotation Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Genome Assembly and Annotation Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Genome Assembly and Annotation Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Genome Assembly and Annotation Service Market Size by Type (2020-2031)
6.4 North America Genome Assembly and Annotation Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Genome Assembly and Annotation Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Genome Assembly and Annotation Service Market Size by Type (2020-2031)
7.4 Europe Genome Assembly and Annotation Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Genome Assembly and Annotation Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Genome Assembly and Annotation Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Genome Assembly and Annotation Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Genome Assembly and Annotation Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Genome Assembly and Annotation Service Market Size by Type (2020-2031)
9.4 Central and South America Genome Assembly and Annotation Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Genome Assembly and Annotation Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Genome Assembly and Annotation Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Genome Assembly and Annotation Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Genome Assembly and Annotation Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Charles River
11.1.1 Charles River Corporation Information
11.1.2 Charles River Business Overview
11.1.3 Charles River Genome Assembly and Annotation Service Product Features and Attributes
11.1.4 Charles River Genome Assembly and Annotation Service Revenue and Gross Margin (2020-2025)
11.1.5 Charles River Genome Assembly and Annotation Service Revenue by Product in 2024
11.1.6 Charles River Genome Assembly and Annotation Service Revenue by Application in 2024
11.1.7 Charles River Genome Assembly and Annotation Service Revenue by Geographic Area in 2024
11.1.8 Charles River Genome Assembly and Annotation Service SWOT Analysis
11.1.9 Charles River Recent Developments
11.2 Lexogen
11.2.1 Lexogen Corporation Information
11.2.2 Lexogen Business Overview
11.2.3 Lexogen Genome Assembly and Annotation Service Product Features and Attributes
11.2.4 Lexogen Genome Assembly and Annotation Service Revenue and Gross Margin (2020-2025)
11.2.5 Lexogen Genome Assembly and Annotation Service Revenue by Product in 2024
11.2.6 Lexogen Genome Assembly and Annotation Service Revenue by Application in 2024
11.2.7 Lexogen Genome Assembly and Annotation Service Revenue by Geographic Area in 2024
11.2.8 Lexogen Genome Assembly and Annotation Service SWOT Analysis
11.2.9 Lexogen Recent Developments
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Corporation Information
11.3.2 Eurofins Scientific Business Overview
11.3.3 Eurofins Scientific Genome Assembly and Annotation Service Product Features and Attributes
11.3.4 Eurofins Scientific Genome Assembly and Annotation Service Revenue and Gross Margin (2020-2025)
11.3.5 Eurofins Scientific Genome Assembly and Annotation Service Revenue by Product in 2024
11.3.6 Eurofins Scientific Genome Assembly and Annotation Service Revenue by Application in 2024
11.3.7 Eurofins Scientific Genome Assembly and Annotation Service Revenue by Geographic Area in 2024
11.3.8 Eurofins Scientific Genome Assembly and Annotation Service SWOT Analysis
11.3.9 Eurofins Scientific Recent Developments
11.4 Natera
11.4.1 Natera Corporation Information
11.4.2 Natera Business Overview
11.4.3 Natera Genome Assembly and Annotation Service Product Features and Attributes
11.4.4 Natera Genome Assembly and Annotation Service Revenue and Gross Margin (2020-2025)
11.4.5 Natera Genome Assembly and Annotation Service Revenue by Product in 2024
11.4.6 Natera Genome Assembly and Annotation Service Revenue by Application in 2024
11.4.7 Natera Genome Assembly and Annotation Service Revenue by Geographic Area in 2024
11.4.8 Natera Genome Assembly and Annotation Service SWOT Analysis
11.4.9 Natera Recent Developments
11.5 BGI
11.5.1 BGI Corporation Information
11.5.2 BGI Business Overview
11.5.3 BGI Genome Assembly and Annotation Service Product Features and Attributes
11.5.4 BGI Genome Assembly and Annotation Service Revenue and Gross Margin (2020-2025)
11.5.5 BGI Genome Assembly and Annotation Service Revenue by Product in 2024
11.5.6 BGI Genome Assembly and Annotation Service Revenue by Application in 2024
11.5.7 BGI Genome Assembly and Annotation Service Revenue by Geographic Area in 2024
11.5.8 BGI Genome Assembly and Annotation Service SWOT Analysis
11.5.9 BGI Recent Developments
11.6 Illumina
11.6.1 Illumina Corporation Information
11.6.2 Illumina Business Overview
11.6.3 Illumina Genome Assembly and Annotation Service Product Features and Attributes
11.6.4 Illumina Genome Assembly and Annotation Service Revenue and Gross Margin (2020-2025)
11.6.5 Illumina Recent Developments
11.7 Roche
11.7.1 Roche Corporation Information
11.7.2 Roche Business Overview
11.7.3 Roche Genome Assembly and Annotation Service Product Features and Attributes
11.7.4 Roche Genome Assembly and Annotation Service Revenue and Gross Margin (2020-2025)
11.7.5 Roche Recent Developments
11.8 LabCorp
11.8.1 LabCorp Corporation Information
11.8.2 LabCorp Business Overview
11.8.3 LabCorp Genome Assembly and Annotation Service Product Features and Attributes
11.8.4 LabCorp Genome Assembly and Annotation Service Revenue and Gross Margin (2020-2025)
11.8.5 LabCorp Recent Developments
11.9 Berry Genomics
11.9.1 Berry Genomics Corporation Information
11.9.2 Berry Genomics Business Overview
11.9.3 Berry Genomics Genome Assembly and Annotation Service Product Features and Attributes
11.9.4 Berry Genomics Genome Assembly and Annotation Service Revenue and Gross Margin (2020-2025)
11.9.5 Berry Genomics Recent Developments
11.10 Brooks Life Sciences
11.10.1 Brooks Life Sciences Corporation Information
11.10.2 Brooks Life Sciences Business Overview
11.10.3 Brooks Life Sciences Genome Assembly and Annotation Service Product Features and Attributes
11.10.4 Brooks Life Sciences Genome Assembly and Annotation Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Macrogen
11.11.1 Macrogen Corporation Information
11.11.2 Macrogen Business Overview
11.11.3 Macrogen Genome Assembly and Annotation Service Product Features and Attributes
11.11.4 Macrogen Genome Assembly and Annotation Service Revenue and Gross Margin (2020-2025)
11.11.5 Macrogen Recent Developments
11.12 Personalis
11.12.1 Personalis Corporation Information
11.12.2 Personalis Business Overview
11.12.3 Personalis Genome Assembly and Annotation Service Product Features and Attributes
11.12.4 Personalis Genome Assembly and Annotation Service Revenue and Gross Margin (2020-2025)
11.12.5 Personalis Recent Developments
11.13 Novogene
11.13.1 Novogene Corporation Information
11.13.2 Novogene Business Overview
11.13.3 Novogene Genome Assembly and Annotation Service Product Features and Attributes
11.13.4 Novogene Genome Assembly and Annotation Service Revenue and Gross Margin (2020-2025)
11.13.5 Novogene Recent Developments
11.14 Genotypic Technology
11.14.1 Genotypic Technology Corporation Information
11.14.2 Genotypic Technology Business Overview
11.14.3 Genotypic Technology Genome Assembly and Annotation Service Product Features and Attributes
11.14.4 Genotypic Technology Genome Assembly and Annotation Service Revenue and Gross Margin (2020-2025)
11.14.5 Genotypic Technology Recent Developments
11.15 Dna Link
11.15.1 Dna Link Corporation Information
11.15.2 Dna Link Business Overview
11.15.3 Dna Link Genome Assembly and Annotation Service Product Features and Attributes
11.15.4 Dna Link Genome Assembly and Annotation Service Revenue and Gross Margin (2020-2025)
11.15.5 Dna Link Recent Developments
12 Genome Assembly and Annotation ServiceIndustry Chain Analysis
12.1 Genome Assembly and Annotation Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Genome Assembly and Annotation Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Genome Assembly and Annotation Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Charles River
Lexogen GmbH
Natera
BGI
Illumina Inc
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link
List of Tables
 Table 1. Global Genome Assembly and Annotation Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Genome Assembly and Annotation Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Genome Assembly and Annotation Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Genome Assembly and Annotation Service Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Genome Assembly and Annotation Service Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Genome Assembly and Annotation Service Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Genome Assembly and Annotation Service Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Genome Assembly and Annotation Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genome Assembly and Annotation Service as of 2024)
 Table 11. Global Genome Assembly and Annotation Service Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Genome Assembly and Annotation Service Companies Headquarters
 Table 13. Global Genome Assembly and Annotation Service Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Genome Assembly and Annotation Service Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Genome Assembly and Annotation Service Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Genome Assembly and Annotation Service Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Genome Assembly and Annotation Service Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Genome Assembly and Annotation Service High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Genome Assembly and Annotation Service Growth Accelerators and Market Barriers
 Table 25. North America Genome Assembly and Annotation Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Genome Assembly and Annotation Service Growth Accelerators and Market Barriers
 Table 27. Europe Genome Assembly and Annotation Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Genome Assembly and Annotation Service Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Genome Assembly and Annotation Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Genome Assembly and Annotation Service Investment Opportunities and Key Challenges
 Table 31. Central and South America Genome Assembly and Annotation Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Genome Assembly and Annotation Service Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Genome Assembly and Annotation Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Charles River Corporation Information
 Table 35. Charles River Description and Major Businesses
 Table 36. Charles River Product Features and Attributes
 Table 37. Charles River Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Charles River Revenue Proportion by Product in 2024
 Table 39. Charles River Revenue Proportion by Application in 2024
 Table 40. Charles River Revenue Proportion by Geographic Area in 2024
 Table 41. Charles River Genome Assembly and Annotation Service SWOT Analysis
 Table 42. Charles River Recent Developments
 Table 43. Lexogen Corporation Information
 Table 44. Lexogen Description and Major Businesses
 Table 45. Lexogen Product Features and Attributes
 Table 46. Lexogen Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Lexogen Revenue Proportion by Product in 2024
 Table 48. Lexogen Revenue Proportion by Application in 2024
 Table 49. Lexogen Revenue Proportion by Geographic Area in 2024
 Table 50. Lexogen Genome Assembly and Annotation Service SWOT Analysis
 Table 51. Lexogen Recent Developments
 Table 52. Eurofins Scientific Corporation Information
 Table 53. Eurofins Scientific Description and Major Businesses
 Table 54. Eurofins Scientific Product Features and Attributes
 Table 55. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Eurofins Scientific Revenue Proportion by Product in 2024
 Table 57. Eurofins Scientific Revenue Proportion by Application in 2024
 Table 58. Eurofins Scientific Revenue Proportion by Geographic Area in 2024
 Table 59. Eurofins Scientific Genome Assembly and Annotation Service SWOT Analysis
 Table 60. Eurofins Scientific Recent Developments
 Table 61. Natera Corporation Information
 Table 62. Natera Description and Major Businesses
 Table 63. Natera Product Features and Attributes
 Table 64. Natera Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Natera Revenue Proportion by Product in 2024
 Table 66. Natera Revenue Proportion by Application in 2024
 Table 67. Natera Revenue Proportion by Geographic Area in 2024
 Table 68. Natera Genome Assembly and Annotation Service SWOT Analysis
 Table 69. Natera Recent Developments
 Table 70. BGI Corporation Information
 Table 71. BGI Description and Major Businesses
 Table 72. BGI Product Features and Attributes
 Table 73. BGI Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. BGI Revenue Proportion by Product in 2024
 Table 75. BGI Revenue Proportion by Application in 2024
 Table 76. BGI Revenue Proportion by Geographic Area in 2024
 Table 77. BGI Genome Assembly and Annotation Service SWOT Analysis
 Table 78. BGI Recent Developments
 Table 79. Illumina Corporation Information
 Table 80. Illumina Description and Major Businesses
 Table 81. Illumina Product Features and Attributes
 Table 82. Illumina Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Illumina Recent Developments
 Table 84. Roche Corporation Information
 Table 85. Roche Description and Major Businesses
 Table 86. Roche Product Features and Attributes
 Table 87. Roche Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Roche Recent Developments
 Table 89. LabCorp Corporation Information
 Table 90. LabCorp Description and Major Businesses
 Table 91. LabCorp Product Features and Attributes
 Table 92. LabCorp Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. LabCorp Recent Developments
 Table 94. Berry Genomics Corporation Information
 Table 95. Berry Genomics Description and Major Businesses
 Table 96. Berry Genomics Product Features and Attributes
 Table 97. Berry Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Berry Genomics Recent Developments
 Table 99. Brooks Life Sciences Corporation Information
 Table 100. Brooks Life Sciences Description and Major Businesses
 Table 101. Brooks Life Sciences Product Features and Attributes
 Table 102. Brooks Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Brooks Life Sciences Recent Developments
 Table 104. Macrogen Corporation Information
 Table 105. Macrogen Description and Major Businesses
 Table 106. Macrogen Product Features and Attributes
 Table 107. Macrogen Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Macrogen Recent Developments
 Table 109. Personalis Corporation Information
 Table 110. Personalis Description and Major Businesses
 Table 111. Personalis Product Features and Attributes
 Table 112. Personalis Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Personalis Recent Developments
 Table 114. Novogene Corporation Information
 Table 115. Novogene Description and Major Businesses
 Table 116. Novogene Product Features and Attributes
 Table 117. Novogene Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Novogene Recent Developments
 Table 119. Genotypic Technology Corporation Information
 Table 120. Genotypic Technology Description and Major Businesses
 Table 121. Genotypic Technology Product Features and Attributes
 Table 122. Genotypic Technology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Genotypic Technology Recent Developments
 Table 124. Dna Link Corporation Information
 Table 125. Dna Link Description and Major Businesses
 Table 126. Dna Link Product Features and Attributes
 Table 127. Dna Link Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. Dna Link Recent Developments
 Table 129. Raw Materials Key Suppliers
 Table 130. Distributors List
 Table 131. Market Trends and Market Evolution
 Table 132. Market Drivers and Opportunities
 Table 133. Market Challenges, Risks, and Restraints
 Table 134. Research Programs/Design for This Report
 Table 135. Key Data Information from Secondary Sources
 Table 136. Key Data Information from Primary Sources


List of Figures
 Figure 1. Genome Assembly and Annotation Service Product Picture
 Figure 2. Global Genome Assembly and Annotation Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Targeted Sequencing Product Picture
 Figure 4. Whole Exome Sequencing Product Picture
 Figure 5. Whole Genome Sequencing Product Picture
 Figure 6. Global Genome Assembly and Annotation Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Hospitals and Clinics
 Figure 8. Biopharma Companies
 Figure 9. Academic & Research Organizations
 Figure 10. Others
 Figure 11. Genome Assembly and Annotation Service Report Years Considered
 Figure 12. Global Genome Assembly and Annotation Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Genome Assembly and Annotation Service Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Genome Assembly and Annotation Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Genome Assembly and Annotation Service Revenue Market Share by Region (2020-2031)
 Figure 16. Global Genome Assembly and Annotation Service Revenue Market Share Ranking (2024)
 Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 18. Targeted Sequencing Revenue Market Share by Player in 2024
 Figure 19. Whole Exome Sequencing Revenue Market Share by Player in 2024
 Figure 20. Whole Genome Sequencing Revenue Market Share by Player in 2024
 Figure 21. Global Genome Assembly and Annotation Service Revenue Market Share by Type (2020-2031)
 Figure 22. Global Genome Assembly and Annotation Service Revenue Market Share by Application (2020-2031)
 Figure 23. North America Genome Assembly and Annotation Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 24. North America Top 5 Players Genome Assembly and Annotation Service Revenue (US$ Million) in 2024
 Figure 25. North America Genome Assembly and Annotation Service Revenue (US$ Million) by Type (2020 - 2031)
 Figure 26. North America Genome Assembly and Annotation Service Revenue (US$ Million) by Application (2020-2031)
 Figure 27. US Genome Assembly and Annotation Service Revenue (2020-2031) & (US$ Million)
 Figure 28. Canada Genome Assembly and Annotation Service Revenue (2020-2031) & (US$ Million)
 Figure 29. Mexico Genome Assembly and Annotation Service Revenue (2020-2031) & (US$ Million)
 Figure 30. Europe Genome Assembly and Annotation Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 31. Europe Top 5 Players Genome Assembly and Annotation Service Revenue (US$ Million) in 2024
 Figure 32. Europe Genome Assembly and Annotation Service Revenue (US$ Million) by Type (2020-2031)
 Figure 33. Europe Genome Assembly and Annotation Service Revenue (US$ Million) by Application (2020-2031)
 Figure 34. Germany Genome Assembly and Annotation Service Revenue (2020-2031) & (US$ Million)
 Figure 35. France Genome Assembly and Annotation Service Revenue (2020-2031) & (US$ Million)
 Figure 36. U.K. Genome Assembly and Annotation Service Revenue (2020-2031) & (US$ Million)
 Figure 37. Italy Genome Assembly and Annotation Service Revenue (2020-2031) & (US$ Million)
 Figure 38. Russia Genome Assembly and Annotation Service Revenue (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Genome Assembly and Annotation Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Asia-Pacific Top 8 Players Genome Assembly and Annotation Service Revenue (US$ Million) in 2024
 Figure 41. Asia-Pacific Genome Assembly and Annotation Service Revenue (US$ Million) by Type (2020-2031)
 Figure 42. Asia-Pacific Genome Assembly and Annotation Service Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Indonesia Genome Assembly and Annotation Service Revenue (2020-2031) & (US$ Million)
 Figure 44. Japan Genome Assembly and Annotation Service Revenue (2020-2031) & (US$ Million)
 Figure 45. South Korea Genome Assembly and Annotation Service Revenue (2020-2031) & (US$ Million)
 Figure 46. Australia Genome Assembly and Annotation Service Revenue (2020-2031) & (US$ Million)
 Figure 47. India Genome Assembly and Annotation Service Revenue (2020-2031) & (US$ Million)
 Figure 48. Indonesia Genome Assembly and Annotation Service Revenue (2020-2031) & (US$ Million)
 Figure 49. Vietnam Genome Assembly and Annotation Service Revenue (2020-2031) & (US$ Million)
 Figure 50. Malaysia Genome Assembly and Annotation Service Revenue (2020-2031) & (US$ Million)
 Figure 51. Philippines Genome Assembly and Annotation Service Revenue (2020-2031) & (US$ Million)
 Figure 52. Singapore Genome Assembly and Annotation Service Revenue (2020-2031) & (US$ Million)
 Figure 53. Central and South America Genome Assembly and Annotation Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 54. Central and South America Top 5 Players Genome Assembly and Annotation Service Revenue (US$ Million) in 2024
 Figure 55. Central and South America Genome Assembly and Annotation Service Revenue (US$ Million) by Type (2020-2031)
 Figure 56. Central and South America Genome Assembly and Annotation Service Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Brazil Genome Assembly and Annotation Service Revenue (2020-2025) & (US$ Million)
 Figure 58. Argentina Genome Assembly and Annotation Service Revenue (2020-2025) & (US$ Million)
 Figure 59. Middle East and Africa Genome Assembly and Annotation Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 60. Middle East and Africa Top 5 Players Genome Assembly and Annotation Service Revenue (US$ Million) in 2024
 Figure 61. South America Genome Assembly and Annotation Service Revenue (US$ Million) by Type (2020-2031)
 Figure 62. Middle East and Africa Genome Assembly and Annotation Service Revenue (US$ Million) by Application (2020-2031)
 Figure 63. GCC Countries Genome Assembly and Annotation Service Revenue (2020-2025) & (US$ Million)
 Figure 64. Israel Genome Assembly and Annotation Service Revenue (2020-2025) & (US$ Million)
 Figure 65. Egypt Genome Assembly and Annotation Service Revenue (2020-2025) & (US$ Million)
 Figure 66. South Africa Genome Assembly and Annotation Service Revenue (2020-2025) & (US$ Million)
 Figure 67. Genome Assembly and Annotation Service Industry Chain Mapping
 Figure 68. Channels of Distribution (Direct Vs Distribution)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Genome Annotation Service Market Research Report 2024
Genome Assembly Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Genome Sequencing Service Market Research Report 2025
Global Whole Genome Sequencing Service Market Research Report 2025
Global Genomics Services Market Research Report 2024
Genome Editing Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Genome Engineering Market Research Report 2024
Global Human Genome Sequencing Market Research Report 2024
Global Whole Genome Sequencers Market Research Report 2024
Global Genome Sequencing Equipment Market Research Report 2025
Global Medical Annotation Service Market Research Report 2024
Global Genome Engineering Editing Market Research Report 2024
Global Epigenome Analysis Services Market Research Report 2024
Global Medical Data Annotation Service Market Research Report 2024
Global Data Annotation Service Market Research Report 2024
Global Gene Service Market Research Report 2025
Whole Genome Resequencing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Image Annotation Service Market Research Report 2024
Global Bioinformatics Sequencing Service Market Research Report 2024
Global Sequencing Services Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions